{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:07:33Z","timestamp":1781482053901,"version":"3.54.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"AstraZeneca Research Trust Fund","award":["ACWAZ1"],"award-info":[{"award-number":["ACWAZ1"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0216656","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T17:30:12Z","timestamp":1558373412000},"page":"e0216656","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Associations of plasma fibroblast growth factor 23 and other markers of chronic kidney disease\u2014Mineral and bone disorder with all-cause mortality in South African patients on maintenance dialysis: A 3-year prospective cohort study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6291-6610","authenticated-orcid":true,"given":"Bala","family":"Waziri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eustasius","family":"Musenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Dix-Peek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vakhtang","family":"Rekhviashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Paget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraladevi","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"T Yamashita","year":"2000","journal-title":"Biochemical and biophysical research communications"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"OM Gutierrez","year":"2008","journal-title":"The New England journal of medicine"},{"issue":"19","key":"ref3","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"OM Gutierrez","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.","volume":"22","author":"M Wolf","year":"2011","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2215\/CJN.02640310","article-title":"Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis","volume":"5","author":"OM Gutierrez","year":"2010","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"issue":"s2","key":"ref6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2362.2006.01665.x","article-title":"Vascular calcification and renal osteodystrophy relationship in chronic kidney disease","volume":"36","author":"SM Moe","year":"2006","journal-title":"European Journal of Clinical Investigation"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1525-139X.2003.16025.x","article-title":"Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis","volume":"16","author":"A Levin","year":"2003","journal-title":"Seminars in dialysis"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/ndt\/gfq191","article-title":"Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?","volume":"25","author":"H Olauson","year":"2010","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"e016528","DOI":"10.1136\/bmjopen-2017-016528","article-title":"Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3","volume":"7","author":"A Shardlow","year":"2017","journal-title":"BMJ open"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1373\/clinchem.2011.172890","article-title":"FGF23: is it ready for prime time?","volume":"57","author":"K Wesseling-Perry","year":"2011","journal-title":"Clinical chemistry"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.07020711","article-title":"Racial differences in markers of mineral metabolism in advanced chronic kidney disease.","volume":"7","author":"A Jovanovich","year":"2012","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ekir.2017.12.004","article-title":"Racial Variations in the Markers of Mineral Bone Disorders in CKD Patients in South Africa","volume":"3","author":"B Waziri","year":"2018","journal-title":"Kidney international reports"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/bmm.16.11","article-title":"Prognostic value of FGF23 among patients with end-stage renal disease: a systematic review and meta-analysis","volume":"10","author":"H Yang","year":"2016","journal-title":"Biomarkers in medicine"},{"issue":"23","key":"ref14","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"T Isakova","year":"2011","journal-title":"Jama"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jbmr.170","article-title":"FGF-23: More than a regulator of renal phosphate handling?","volume":"25","author":"H Juppner","year":"2010","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.","volume":"26","author":"J Floege","year":"2011","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.","volume":"15","author":"GA Block","year":"2004","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12882-016-0377-5","article-title":"Fatal outcomes among patients on maintenance haemodialysis in sub-Saharan Africa: a 10-year audit from the Douala General Hospital in Cameroon","volume":"17","author":"MP Halle","year":"2016","journal-title":"BMC nephrology"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"e0156642","DOI":"10.1371\/journal.pone.0156642","article-title":"Baseline Predictors of Mortality among Predominantly Rural-Dwelling End-Stage Renal Disease Patients on Chronic Dialysis Therapies in Limpopo, South Africa","volume":"11","author":"RA Tamayo Isla","year":"2016","journal-title":"PloS one"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"T Isakova","year":"2011","journal-title":"Jama"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and mortality in dialysis patients.","volume":"6","author":"C Drechsler","year":"2011","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/ndt\/gfq144","article-title":"Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.","volume":"25","author":"CP Kovesdy","year":"2010","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"5\u20136","key":"ref23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lfs.2011.11.006","article-title":"Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients","volume":"90","author":"I Kobayashi","year":"2012","journal-title":"Life sciences"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters","volume":"92","author":"M Ketteler","year":"2017","journal-title":"Kidney international"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.","volume":"22","author":"J Kendrick","year":"2011","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00774-005-0625-4","article-title":"Comparison of two assays for fibroblast growth factor (FGF)-23","volume":"23","author":"N Ito","year":"2005","journal-title":"Journal of bone and mineral metabolism"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1210\/jc.2012-1811","article-title":"Biological variability of plasma intact and C-terminal FGF23 measurements","volume":"97","author":"ER Smith","year":"2012","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2013.7228","article-title":"Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events","volume":"310","author":"C Robinson-Cohen","year":"2013","journal-title":"Jama"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1093\/ndt\/gfq316","article-title":"Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.","volume":"25","author":"OM Gutierrez","year":"2010","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"JJ Scialla","year":"2013","journal-title":"Kidney international"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy","volume":"22","author":"A Grabner","year":"2015","journal-title":"Cell metabolism"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2795432","DOI":"10.1155\/2017\/2795432","article-title":"High Serum Alkaline Phosphatase, Hypercalcaemia, Race, and Mortality in South African Maintenance Haemodialysis Patients.","volume":"2017","author":"B Waziri","year":"2017","journal-title":"International journal of nephrology"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jc.2016-2215","article-title":"Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study","volume":"101","author":"N Souma","year":"2016","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","article-title":"Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.","volume":"26","author":"M Naves-Diaz","year":"2011","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study.","volume":"16","author":"M Teng","year":"2005","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ndt\/gfs404","article-title":"Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?","volume":"28","author":"D Fouque","year":"2013","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).","volume":"52","author":"F Tentori","year":"2008","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"26","key":"ref38","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"GM Chertow","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1097\/01.ASN.0000145894.57533.C4","article-title":"Vascular calcification mechanisms.","volume":"15","author":"CM Giachelli","year":"2004","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"758450","DOI":"10.4061\/2011\/758450","article-title":"Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients.","volume":"2011","author":"P Bolasco","year":"2011","journal-title":"International journal of nephrology"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis.","volume":"20","author":"T Isakova","year":"2009","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1681\/ASN.2017070772","article-title":"Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.","volume":"29","author":"T Isakova","year":"2018","journal-title":"Journal of the American Society of Nephrology: JASN"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0216656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:56:03Z","timestamp":1588964163000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0216656"}},"subtitle":[],"editor":[{"given":"Kathleen M.","family":"Hill Gallant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0216656","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,20]]}}}